未登录

R

Rachel J. Meadows

jps health network

H指数:10

被引数:468

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Implementation strategies to increase cardiorenal-protective antidiabetic prescribing: A scoping review

增加心血管-肾脏保护性抗糖尿病药物处方的实施策略：一项范围综述

Annals of Epidemiology

IF3

2026-07-180

PRE

Lessons Learned From the Implementation of a Clinic-Focused HPV Vaccination Initiative

从一项以诊所为重点的HPV疫苗接种倡议实施中汲取的经验教训

journal of primary care and community health

IF0

2026-03-180

PRE

Complex, multilevel barriers and solutions for nutrition security in the USA: a community-based participatory research approach

美国营养安全中的复杂、多层次障碍与对策：基于社区参与式研究的方法

BMJ Public Health

IF0

2025-12-010

OA

Socio-demographic differences in the dietary inflammatory index from National Health and Nutrition Examination Survey 2005-2018: a comparison of multiple imputation versus complete case analysis

PUBLIC HEALTH NUTRITION

IF3

2024-09-270

OAAI

Prevalence of Multimorbidity Among Patients with Newly Diagnosed Cancer at a Safety-Net Health System

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2024-09-210

PRE

Comparative effectiveness of treatment approaches for early invasive breast cancer

ANNALS OF EPIDEMIOLOGY

IF3

2024-08-010

OAAI

Evaluation of a human papillomavirus vaccination training implementation in clinical and community settings across different clinical roles

TRANSLATIONAL BEHAVIORAL MEDICINE

IF3

2024-03-092

PRE

Risk-management decision-making data from a community-based sample of racially diverse women at high risk of breast cancer: rationale, methods, and sample characteristics of the Daughter Sister Mother Project survey

BREAST CANCER RESEARCH

IF5.6

2024-01-113

OAAI

We care but we're not carers: perceptions and experiences of social prescribing in a UK national community organisation

PERSPECTIVES IN PUBLIC HEALTH

IF2.6

2023-07-254

OAAI

Survival After Implementation of a Decision Support Tool to Facilitate Evidence-Based Cancer Treatment

JCO CLINICAL CANCER INFORMATICS

IF2.8

2023-06-010

OAAI

Cardiotoxicity among socioeconomically marginalized breast cancer patients

BREAST CANCER RESEARCH AND TREATMENT

IF3

2022-08-153

OAAI

Timing of adjuvant chemotherapy initiation and mortality among colon cancer patients at a safety-net health system

IF3.4

2022-05-318

OAAI

Cardiotoxicity among socioeconomically disadvantaged breast cancer patients

CANCER RESEARCH

IF16.6

2022-02-150

PRE

Impact of prognostic factor distributions on mortality disparities for socioeconomically disadvantaged cancer patients

ANNALS OF EPIDEMIOLOGY

IF3

2022-01-015

PRE

The efficacy and cost-effectiveness of patient navigation programs across the cancer continuum: A systematic review

IF5.1

2019-04-29135

OAAI